March 13, 2018 / 11:13 AM / 6 months ago

BRIEF-Antares Pharma Q4 Loss Per Share $0.02

March 13 (Reuters) - Antares Pharma Inc:

* ANTARES PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2017 OPERATING AND FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.02

* Q4 EARNINGS PER SHARE VIEW $-0.03 — THOMSON REUTERS I/B/E/S

* ANTARES PHARMA - QTRLY TOTAL REVENUE $14.0 MILLION VERSUS $14.2 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below